Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-bin Liu

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 21, 2017
MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder CancerHai-Bin Liang, Yang Cao, Qiang Ma, et al.
Cancer Medicine|September 20, 2022
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II studyGuo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, et al.
World Journal of Gastrointestinal Surgery|March 1, 2021
Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: Results from 24 hospitals in ChinaTai Ren, Yong-Sheng Li, Xue-Yi Dang, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|August 20, 2014
Diagnosis and treatment of cholangiocarcinoma: a consensus from surgical specialists of ChinaJian-Qiang Cai, Shou-Wang Cai, Wen-Ming Cong, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 21, 2017
MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder CancerHai-Bin Liang, Yang Cao, Qiang Ma, et al.
Cancer Medicine|September 20, 2022
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II studyGuo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, et al.
World Journal of Gastrointestinal Surgery|March 1, 2021
Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: Results from 24 hospitals in ChinaTai Ren, Yong-Sheng Li, Xue-Yi Dang, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|August 20, 2014
Diagnosis and treatment of cholangiocarcinoma: a consensus from surgical specialists of ChinaJian-Qiang Cai, Shou-Wang Cai, Wen-Ming Cong, et al.
Pageof 14